BCS Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Buy
1,962
+137
+8% +$140K 0.42% 54
2026
Q1
$1.68M Sell
1,825
-1,815
-50% -$1.84M 0.34% 65
2025
Q4
$3.91M Sell
3,640
-655
-15% -$626K 0.4% 56
2025
Q3
$3.28M Sell
4,295
-796
-16% -$592K 0.74% 35
2025
Q2
$3.97M Buy
5,091
+183
+4% +$142K 0.85% 32
2025
Q1
$4.05M Sell
4,908
-167
-3% -$139K 1.04% 27
2024
Q4
$3.92M Buy
+5,075
New +$4.2M 0.97% 30
2024
Q2
Sell
-4,470
Closed -$3.48M 188
2024
Q1
$3.48M Buy
4,470
+513
+13% +$365K 1.12% 19
2023
Q4
$2.31M Hold
3,957
0.85% 30
2023
Q3
$2.13M Buy
+3,957
New +$2.04M 0.88% 29
2023
Q2
Sell
-3,898
Closed -$1.34M 141
2023
Q1
$1.34M Sell
3,898
-28
-0.7% -$9.44K 0.61% 40
2022
Q4
$1.44M Hold
3,926
0.6% 44
2022
Q3
$1.27M Sell
3,926
-60
-2% -$19K 0.6% 44
2022
Q2
$1.29M Buy
3,986
+59
+2% +$17.7K 0.57% 43
2022
Q1
$1.13M Sell
3,927
-1,947
-33% -$501K 0.47% 49
2021
Q4
$1.62M Buy
5,874
+926
+19% +$235K 0.58% 43
2021
Q3
$1.14M Buy
4,948
+7
+0.1% +$1.73K 0.49% 49
2021
Q2
$1.13M Buy
4,941
+4
+0.1% +$803 0.6% 39
2021
Q1
$922K Buy
4,937
+4
+0.1% +$782 0.44% 48
2020
Q4
$833K Buy
4,933
+30
+0.6% +$4.48K 0.43% 54
2020
Q3
$726K Buy
4,903
+5
+0.1% +$774 0.41% 51
2020
Q2
$804K Hold
4,898
0.48% 47
2020
Q1
$679K Buy
+4,898
New +$673K 0.48% 45

Other funds holding LLY

BCS Wealth Management's LLY Position: Q2 2026 in Review

BCS Wealth Management increased its Eli Lilly (LLY) stake by 7.5% in Q2 2026, buying an estimated $140K and bringing the position to 1,962 shares worth $2.35M. The position accounts for 0.42% of the portfolio, ranked #54.

BCS Wealth Management first reported a position in LLY in Q1 2020 and has held it in 23 quarters since. The position peaked at $4.05M in Q1 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BCS Wealth Management held 1,962 shares of Eli Lilly worth $2.35M as of Q2 2026.
  • BCS Wealth Management bought 137 Eli Lilly shares in Q2 2026, an estimated $140K.
  • Eli Lilly made up 0.42% of BCS Wealth Management's portfolio in Q2 2026, its #54 holding.
  • BCS Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 23 quarters since.
  • BCS Wealth Management's Eli Lilly position peaked at $4.05M in Q1 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BCS Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.